Search - tctmd.com

Displaying 681 - 700 of 1172

Sort: Relevancy | Date

News Conference News AHA 2017

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

Todd Neale

November 15, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

Presentation TCT 2017

Factors Affecting Evaluation for Ischemic Heart Disease and Cath Lab Referral

Presenter: Alice K. Jacobs, Spencer B. King III

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

Slovenia Presents: MitraClip in Severe Ischemic Heart Disease - Hybrid Treatment Approach

Presenter: Emmanouil I Skalidis, Matjaz Bunc

October 31, 2017

Presentation TCT 2017

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Presenter: Vasilis Babaliaros, Shmuel Banai, Andrew Wechsler

October 30, 2017

Presentation TCT 2017

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

News Daily News

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Michael O'Riordan

October 26, 2017

Advertisement

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Live From Denver: TCT 2017, Day Four

Factors Affecting Evaluation for Ischemic Heart Disease and Cath Lab Referral

Long-term Absorb BVS Data Continue to Disappoint

Slovenia Presents: MitraClip in Severe Ischemic Heart Disease - Hybrid Treatment Approach

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

The Inflammatory Hypothesis After CANTOS: CIRT

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Should Alleviating ISCHEMIA Be the Goal?

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Lp(a) Not Associated With Adverse Cardiovascular Events in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content